FLT3;KIT;PKC;PDGFR
Assets acting on this target.
- Class
- Reversible multitargeted non-covalent kinase inhibitor
- Notes
- audit finding #658 (material); source: https://clinicaltrials.gov/api/v2/studies/NCT04027309
Related mechanisms
Multi-kinase inhibitor (VEGFR/PDGFR/KIT) (2)c-Kit, VEGFR2 (KDR), PDGFRbeta, VEGFR3, FLT1, FLT3 (1)FLT3 (including D835/ITD mutants), also PDGFR-alpha/beta (1)FLT3 (wild-type and mutant, including ITD/TKD), SYK, JAK1/2, mutant KIT, RSK2 (1)KIT (c-Kit), also PDGFR and Lyn/Fyn kinases (1)PDGFR/CSF1R/KIT (multi-kinase) (1)